All In Biotech

Free tool

FAERS Monitor: Decitabine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205582 or its brand name (Decitabine, Decitabine). Reports on generic versions are filed under their own applications.

Reports

4,367

Serious

4,145

95% of reports

Hospitalization

1,567

Death reported

1,166

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use508
  • febrile neutropenia456
  • myelosuppression438
  • drug ineffective349
  • neutropenia334
  • pneumonia325
  • thrombocytopenia291
  • death287
  • pyrexia263
  • acute myeloid leukaemia242
  • anaemia218
  • product use in unapproved indication218
  • sepsis207
  • disease progression192
  • nausea183

Reports by year received

View as table
YearReports
20051
20061
20077
200811
200943
201029
2011123
2012132
201386
201475
201575
2016103
2017172
2018249
2019322
2020491
2021451
2022517
2023452
2024367
2025343
2026317

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,792 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute myeloid leukaemiaSignal24275.967.117,560
myelosuppressionSignal43859.354.224,775
febrile neutropeniaSignal45633.330.514,215
thrombocytopeniaSignal29112.611.23,094
neutropeniaSignal33411.910.73,323
sepsisSignal2079.07.81,459
disease progressionSignal1927.86.81,141
anaemiaSignal2185.54.8807
pneumoniaSignal3254.84.41,000
product use in unapproved indicationSignal2184.23.7542
pyrexiaSignal2633.73.3515
off label useSignal5082.82.6609
death2871.61.468
drug ineffective3491.31.222
nausea1831.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.